Alexander W D, Branch R A, Levine D F, Hartog M
Postgrad Med J. 1977 Mar;53(617):117-21. doi: 10.1136/pgmj.53.617.117.
Nineteen patients with severe oedema due to either cirrhosis of the liver or to congestive cardiac failure, who had failed to respond to previous diuretic therapy, were treated with either increasing doses of frusemide (Group A), or with frusemide in a fixed dose of 80 mg daily and increasing doses of spironolactone (Group B). In Group A there was an inverse correlation between the baseline 24-hr urinary sodium: potassium (Na : K) ratio and the 24-hr urinary potassium excretion during diuresis, and a direct correlation between the urinary Na : K ratio before and after diuresis. Thus, in patients of this group during diuresis, there was a significantly higher urinary potassium excretion in those with a baseline urinary Na : K ratio of less than 1, as compared with those with a ratio of greater than 1. In Group B a satisfactory diuresis was achieved without marked urinary potassium loss in those patients with a baseline urinary Na : K ratio of less than 1, whereas no diuresis was obtained in the two patients with a baseline urinary Na : K ratio of greater than 1. These results suggest that the measurement of the baseline urinary Na : K ratio is of help in determining the potential value of spironolactone in patients with resistant oedema.
19例因肝硬化或充血性心力衰竭导致严重水肿且对先前利尿剂治疗无反应的患者,分别接受递增剂量的速尿治疗(A组),或每日固定剂量80mg速尿加递增剂量螺内酯治疗(B组)。A组中,基线24小时尿钠:钾(Na:K)比值与利尿期间24小时尿钾排泄呈负相关,利尿前后尿Na:K比值呈正相关。因此,该组患者在利尿期间,基线尿Na:K比值小于1的患者尿钾排泄显著高于比值大于1的患者。B组中,基线尿Na:K比值小于1的患者在无明显尿钾丢失的情况下实现了满意的利尿效果,而基线尿Na:K比值大于1的两名患者未出现利尿。这些结果表明,测量基线尿Na:K比值有助于确定螺内酯在顽固性水肿患者中的潜在价值。